1. Home
  2. AXGN

AXGN

Axogen Inc.

Logo Axogen Inc.

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Founded: N/A Country:
United States
United States
Employees: N/A City: ALACHUA
Market Cap: 340.8M IPO Year: N/A
Target Price: $13.60 AVG Volume (30 days): 407.5K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.51 EPS Growth: N/A
52 Week Low/High: $3.45 - $10.83 Next Earning Date: 05-07-2024
Revenue: $159,012,000 Revenue Growth: 14.74%
Revenue Growth (this year): 15.15% Revenue Growth (next year): 12.80%

Share on Social Networks: